| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_994d1034e8cc636d2029b05fc7aa2ed2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_85b959d2100bb308fcf773d125a37ab8 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-325 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-566
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-566 |
| filingDate |
2014-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e9d1f07da090f16a70f2058520782ed
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b7eb5f47ac59093b18888291709df302
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d513dac188f5316b3a5d5a9f26488b03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_713a7cf6f82f98a135db0a242232dc1b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac2cbb8dd06a403aa1110c2c930b5844
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf5f643288c547a6ef9205f739ec4329
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b85c3f8a009133b721240e7156409130
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80d1e4a3f57818fff957549f4ac1d646
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_923ebe2eb29e5276c57ecf86b6251e0c |
| publicationDate |
2014-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2014193845-A1 |
| titleOfInvention |
Use of sfrp-3 in the assessment of heart failure |
| abstract |
Disclosed is a method for assessing heart failure in vitro including the steps of measuring in a sample the concentration of the marker SFRP-3, of optionally measuring in the sample the concentration of one or more other marker(s) of heart failure, and of assessing heart failure by comparing the concentration determined in for SFRP-3 and the concentration(s) determined for the optionally one or more other marker to the concentration of this marker or these markers as established in a reference population. Also disclosed are the use of SFRP-3 as a marker protein in the assessment of heart failure, a marker combination comprising SFRP-3 and a kit for measuring SFRP-3. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022066714-A3 |
| priorityDate |
2008-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |